infection with SARS-CoV-2 during pregnancy
Conditions
Interventions
Group 1: A venous blood sample is taken from all pregnant women tested positively for SARS-CoV-2 and analyzed for IgG and IgA antibodies. Furthermore, cord blood of the newborns of these women is anal
Sponsors
Kepler Universitätsklinikum Linz, Med Campus IV, Klinik für Gynäkologie, Geburtshilfe und gyn. Endokrinologie
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: - All pregnant women tested positively for SARS-CoV-2 during pregnancy and all those with signs of SARS-CoV-2 infection due to their symptoms who are planning on giving birth at Kepler University Clinic Linz, Salzkammergut Clinic Vöcklabruck and Phyrn-Eisenwurzen Hospital Steyr. - A control group of healthy pregnant women matched 1:1 for gestational age at birth.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The aim of the study is to rule out the transmission of SARS-CoV-2 in patients with laboratory-confirmed infection onto their newborns in utero and to confirm the development of immunity through IgG antibodies. | — |
Secondary
| Measure | Time frame |
|---|---|
| Comparison of demographic data such as underlying conditions in the mother, current medication, birth outcome and important parameters concerning the newborn (birth weight, breastfeeding, 24-h-survival rate, admission to NICU/NIMCU) with a healthy control group matched for gestational age at birth. | — |
Countries
Austria
Contacts
Public ContactSabine Enengl
Kepler Universitätsklinikum Linz, Med Campus IV, Klinik für Gynäkologie, Geburtshilfe und gyn. Endokrinologie
Outcome results
None listed